Canada Pension Plan Investment Board’s Bristol-Myers Squibb BMY Stock Holding History

Canada Pension Plan Investment Board’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$248M	Sell	4,095,618 -422,719	-9%	-$24.6M	0.16%	142
2025 Q4	$244M	Buy	4,518,337 +2,060,854	+84%	+$99.1M	0.16%	133
2025 Q3	$111M	Hold	2,457,483	–	–	0.08%	217
2025 Q2	$114M	Sell	2,457,483 -92,300	-4%	-$4.53M	0.1%	185
2025 Q1	$156M	Sell	2,549,783 -1,552,813	-38%	-$90.5M	0.15%	138
2024 Q4	$232M	Sell	4,102,596 -458,380	-10%	-$25.6M	0.22%	90
2024 Q3	$236M	Sell	4,560,976 -379,542	-8%	-$17.8M	0.22%	109
2024 Q2	$205M	Buy	4,940,518 +108,956	+2%	+$4.88M	0.2%	115
2024 Q1	$262M	Buy	4,831,562 +325,585	+7%	+$16.6M	0.28%	86
2023 Q4	$231M	Buy	4,505,977 +994,449	+28%	+$52.2M	0.29%	90
2023 Q3	$204M	Buy	3,511,528 +915,400	+35%	+$56.1M	0.3%	84
2023 Q2	$166M	Buy	2,596,128 +124,969	+5%	+$8.38M	0.25%	97
2023 Q1	$171M	Sell	2,471,159 -120,330	-5%	-$8.49M	0.27%	94
2022 Q4	$186M	Sell	2,591,489 -377,021	-13%	-$28.4M	0.33%	80
2022 Q3	$211M	Sell	2,968,510 -2,773,412	-48%	-$201M	0.36%	74
2022 Q2	$442M	Buy	5,741,922 +2,711,900	+90%	+$207M	0.73%	33
2022 Q1	$221M	Sell	3,030,022 -678,846	-18%	-$45.6M	0.3%	89
2021 Q4	$231M	Sell	3,708,868 -1,801,344	-33%	-$106M	0.25%	104
2021 Q3	$326M	Buy	5,510,212 +261,959	+5%	+$17.3M	0.37%	72
2021 Q2	$351M	Buy	5,248,253 +1,045,713	+25%	+$68.2M	0.42%	59
2021 Q1	$265M	Buy	4,202,540 +1,929,721	+85%	+$120M	0.35%	70
2020 Q4	$141M	Sell	2,272,819 -245,426	-10%	-$15.1M	0.21%	104
2020 Q3	$152M	Buy	2,518,245 +586,148	+30%	+$35.3M	0.29%	82
2020 Q2	$114M	Sell	1,932,097 -289,028	-13%	-$17.3M	0.24%	86
2020 Q1	$124M	Buy	2,221,125 +365,408	+20%	+$22.3M	0.33%	67
2019 Q4	$119M	Sell	1,855,717 -86,059	-4%	-$4.93M	0.23%	87
2019 Q3	$98.5M	Sell	1,941,776 -989,059	-34%	-$46.5M	0.2%	98
2019 Q2	$133M	Buy	2,930,835 +248,935	+9%	+$11.6M	0.27%	79
2019 Q1	$128M	Sell	2,681,900 -486,409	-15%	-$24.2M	0.25%	83
2018 Q4	$165M	Sell	3,168,309 -2,302,300	-42%	-$124M	0.37%	60
2018 Q3	$340M	Buy	5,470,609 +241,700	+5%	+$14.3M	0.63%	37
2018 Q2	$289M	Sell	5,228,909 -84,384	-2%	-$4.56M	0.56%	41
2018 Q1	$336M	Buy	5,313,293 +554,584	+12%	+$35.7M	0.57%	40
2017 Q4	$292M	Sell	4,758,709 -243,500	-5%	-$15.2M	0.55%	40
2017 Q3	$319M	Buy	5,002,209 +683,400	+16%	+$39.9M	0.65%	35
2017 Q2	$241M	Buy	4,318,809 +956,200	+28%	+$52M	0.55%	36
2017 Q1	$183M	Buy	3,362,609 +646,000	+24%	+$35.4M	0.48%	41
2016 Q4	$159M	Sell	2,716,609 -225,300	-8%	-$12.3M	0.58%	38
2016 Q3	$159M	Buy	2,941,909 +1,307,141	+80%	+$84M	0.58%	35
2016 Q2	$120M	Buy	1,634,768 +310,947	+23%	+$22M	0.49%	35
2016 Q1	$84.6M	Buy	1,323,821 +1,142,200	+629%	+$72M	0.35%	46
2015 Q4	$12.5M	Sell	181,621 -786,747	-81%	-$52M	0.06%	294
2015 Q3	$57.3M	Sell	968,368 -110,400	-10%	-$7M	0.24%	74
2015 Q2	$71.8M	Buy	1,078,768 +345,800	+47%	+$22.8M	0.23%	72
2015 Q1	$47.3M	Sell	732,968 -612,301	-46%	-$38.3M	0.17%	116
2014 Q4	$79.4M	Buy	1,345,269 +934,148	+227%	+$52.7M	0.25%	74
2014 Q3	$21M	Sell	411,121 -8,091	-2%	-$404K	0.07%	256
2014 Q2	$20.3M	Sell	419,212 -152,599	-27%	-$7.52M	0.07%	286
2014 Q1	$29.7M	Buy	571,811 +129,406	+29%	+$6.89M	0.12%	176
2013 Q4	$23.5M	Buy	442,405 +22,790	+5%	+$1.16M	0.1%	219
2013 Q3	$19.4M	Buy	419,615 +87,788	+26%	+$3.85M	0.09%	270
2013 Q2	$14.8M	Buy	+331,827	New	+$14.4M	0.07%	298

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Canada Pension Plan Investment Board's BMY Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Bristol-Myers Squibb (BMY) stake by 9.4% in Q1 2026, selling an estimated $24.6M and leaving 4,095,618 shares worth $248M. The position accounts for 0.16% of the portfolio, ranked #142.

Canada Pension Plan Investment Board first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $442M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Canada Pension Plan Investment Board held 4,095,618 shares of Bristol-Myers Squibb worth $248M as of Q1 2026.
Canada Pension Plan Investment Board sold 422,719 Bristol-Myers Squibb shares in Q1 2026, an estimated $24.6M.
Bristol-Myers Squibb made up 0.16% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #142 holding.
Canada Pension Plan Investment Board first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
Canada Pension Plan Investment Board's Bristol-Myers Squibb position peaked at $442M in Q2 2022.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.